Eikon Therapeutics, Inc. (EIKN): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in EIKN. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
6
13F filers
Aggregate Value
$12.0M
Across holders
Last Price
$7.50
2026-10-08
Sector
—
GICS
Quarterly fund activity2 increased2 reduced2 exited
Full exits: Hudson Bay Capital Management LP, Squarepoint Ops LLC
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP CIK 0001263508 | Hedge Fund | 556K | $7.2M | 60.2% | 0.0% | Unchanged | +$0 | Q2 2026 |
| Schonfeld Strategic Advisors LLC CIK 0001665241 | Hedge Fund | 180K | $2.3M | 19.5% | 0.0% | Added | — | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 133K | $1.7M | 14.4% | 0.0% | Reduced | $-556K | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 27K | $350K | 2.9% | 0.0% | Added | — | Q2 2026 |
| TUDOR INVESTMENT CORP ET AL CIK 0000923093 | Hedge Fund | 15K | $196K | 1.6% | 0.0% | Unchanged | +$0 | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 13K | $170K | 1.4% | 0.0% | Reduced | $-3.9M | Q2 2026 |
Unchanged
Hedge Fund
$7.2M· 60.2% of total· 0.0% port· 556K sh· +$0 QoQ· Q2 2026
Added
Hedge Fund
$2.3M· 19.5% of total· 0.0% port· 180K sh· — QoQ· Q2 2026
Reduced
Hedge Fund
$1.7M· 14.4% of total· 0.0% port· 133K sh· $-556K QoQ· Q2 2026
Added
Hedge Fund
$350K· 2.9% of total· 0.0% port· 27K sh· — QoQ· Q2 2026
Unchanged
Hedge Fund
$196K· 1.6% of total· 0.0% port· 15K sh· +$0 QoQ· Q2 2026
Reduced
Hedge Fund
$170K· 1.4% of total· 0.0% port· 13K sh· $-3.9M QoQ· Q2 2026
Loading recent insider activity…